Waterloo Capital L.P. lowered its stake in The Clorox Company (NYSE:CLX – Free Report) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,317 shares of the company’s stock after selling 94 shares during the quarter. Waterloo Capital L.P.’s holdings in Clorox were worth $539,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Brooklyn Investment Group boosted its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Continuum Advisory LLC lifted its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Millstone Evans Group LLC bought a new position in Clorox during the 4th quarter valued at $31,000. Asset Planning Inc acquired a new position in shares of Clorox during the 4th quarter valued at $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new position in shares of Clorox during the 4th quarter valued at $36,000. Institutional investors own 78.53% of the company’s stock.
Analysts Set New Price Targets
CLX has been the subject of several research reports. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Barclays lowered their price objective on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a research note on Thursday, March 27th. Wells Fargo & Company reduced their target price on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a report on Wednesday, April 2nd. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. increased their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $159.00.
Clorox Trading Down 3.3 %
Clorox stock opened at $143.76 on Monday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market capitalization of $17.71 billion, a PE ratio of 39.28, a PEG ratio of 2.62 and a beta of 0.45. The business’s 50-day simple moving average is $150.06 and its 200-day simple moving average is $158.36.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm posted $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.39%. Clorox’s dividend payout ratio is currently 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What is the NASDAQ Stock Exchange?
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Stock Average Calculator
- Disney 2025 Shareholders: Major Updates for Investors
- How to Profit From Value Investing
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.